Viewing offline content

Limited functionality available

Dismiss
United States
  • Services

    What's New

    • Register for Dbriefs webcasts

    • Unlimited Reality™

      Metaverse solutions that drive value

    • Sustainability, Climate & Equity

      Cultivating a sustainable and prosperous future

    • Tax

      • Tax Operate
      • Tax Legislation
      • Tax Technology Consulting
      • Mobility and Payroll
      • Legal Business Services
      • Tax Services
    • Consulting

      • Core Business Operations
      • Customer & Marketing
      • Enterprise Technology & Performance
      • Human Capital
      • Strategy & Analytics
    • Audit & Assurance

      • Audit Innovation
      • Accounting Standards
      • Accounting Events & Transactions
    • Deloitte Private

    • M&A and Restructuring

    • Risk & Financial Advisory

      • Accounting & Internal Controls
      • Cyber & Strategic Risk
      • Regulatory & Legal
      • Transactions and M&A
    • AI & Analytics

    • Cloud

    • Diversity, Equity & Inclusion

  • Industries

    What's New

    • The Ripple Effect

      Real-world client stories of purpose and impact

    • Register for Dbriefs webcasts

    • Industry Outlooks

      Key opportunities, trends, and challenges

    • Consumer

      • Automotive
      • Consumer Products
      • Retail, Wholesale & Distribution
      • Transportation, Hospitality & Services
    • Energy, Resources & Industrials

      • Industrial Products & Construction
      • Power, Utilities & Renewables
      • Energy & Chemicals
      • Mining & Metals
    • Financial Services

      • Banking & Capital Markets
      • Insurance
      • Investment Management
      • Real Estate
    • Government & Public Services

      • Defense, Security & Justice
      • Federal health
      • Civil
      • State & Local
      • Higher Education
    • Life Sciences & Health Care

      • Health Care
      • Life Sciences
    • Technology, Media & Telecommunications

      • Technology
      • Telecommunications, Media & Entertainment
  • Insights

    Deloitte Insights

    What's New

    • Deloitte Insights Magazine

      Explore the latest issue now

    • Deloitte Insights app

      Go straight to smart with daily updates on your mobile device

    • Weekly economic update

      See what's happening this week and the impact on your business

    • Strategy

      • Business Strategy & Growth
      • Digital Transformation
      • Governance & Board
      • Innovation
      • Marketing & Sales
      • Private Enterprise
    • Economy & Society

      • Economy
      • Environmental, Social, & Governance
      • Health Equity
      • Trust
      • Mobility
    • Organization

      • Operations
      • Finance & Tax
      • Risk & Regulation
      • Supply Chain
      • Smart Manufacturing
    • People

      • Leadership
      • Talent & Work
      • Diversity, Equity, & Inclusion
    • Technology

      • Data & Analytics
      • Emerging Technologies
      • Technology Management
    • Industries

      • Consumer
      • Energy, Resources, & Industrials
      • Financial Services
      • Government & Public Services
      • Life Sciences & Health Care
      • Technology, Media, & Telecommunications
    • Spotlight

      • Deloitte Insights Magazine
      • Press Room Podcasts
      • Weekly Economic Update
      • COVID-19
      • Resilience
      • Top 10 reading guide
  • Careers

    What's New

    • Our Purpose

      Exceptional organizations are led by a purpose. At Deloitte, our purpose is to make an impact that matters by creating trust and confidence in a more equitable society.

    • Day in the Life: Our hybrid workplace model

      See how we connect, collaborate, and drive impact across various locations.

    • The Deloitte University Experience

      Explore Deloitte University like never before through a cinematic movie trailer and films of popular locations throughout Deloitte University.

    • Careers

      • Audit & Assurance
      • Consulting
      • Risk & Financial Advisory
      • Tax
      • Internal Services
      • US Delivery Center
    • Students

      • Undergraduate
      • Advanced Degree
      • Internships
    • Experienced Professionals

      • Additional Opportunities
      • Veterans
      • Industries
      • Executives
    • Job Search

      • Entry Level Jobs
      • Experienced Professional Jobs
      • Recruiting Tips
      • Explore Your Fit
      • Labor Condition Applications
    • Life at Deloitte

      • Life at Deloitte Blog
      • Meet Our People
      • Diversity, Equity, & Inclusion
      • Corporate Citizenship
      • Leadership Development
      • Empowered Well-Being
      • Deloitte University
    • Alumni Relations

      • Update Your Information
      • Events
      • Career Development Support
      • Marketplace Jobs Dashboard
      • Alumni Resources
  • US-EN Location: United States-English  
  • Contact us
  • US-EN Location: United States-English  
  • Contact us
    • Dashboard
    • Saved items
    • Content feed
    • Subscriptions
    • Profile/Interests
    • Account settings

Welcome back

Still not a member? Join My Deloitte

CDOs, health data, and the Open Science movement

by Dr. Juergen Klenk
  • Save for later
  • Download
  • Share
    • Share on Facebook
    • Share on Twitter
    • Share on Linkedin
    • Share by email
Deloitte Insights
  • Strategy
    Strategy
    Strategy
    • Business Strategy & Growth
    • Digital Transformation
    • Governance & Board
    • Innovation
    • Marketing & Sales
    • Private Enterprise
  • Economy & Society
    Economy & Society
    Economy & Society
    • Economy
    • Environmental, Social, & Governance
    • Health Equity
    • Trust
    • Mobility
  • Organization
    Organization
    Organization
    • Operations
    • Finance & Tax
    • Risk & Regulation
    • Supply Chain
    • Smart Manufacturing
  • People
    People
    People
    • Leadership
    • Talent & Work
    • Diversity, Equity, & Inclusion
  • Technology
    Technology
    Technology
    • Data & Analytics
    • Emerging Technologies
    • Technology Management
  • Industries
    Industries
    Industries
    • Consumer
    • Energy, Resources, & Industrials
    • Financial Services
    • Government & Public Services
    • Life Sciences & Health Care
    • Tech, Media, & Telecom
  • Spotlight
    Spotlight
    Spotlight
    • Deloitte Insights Magazine
    • Press Room Podcasts
    • Weekly Economic Update
    • COVID-19
    • Resilience
    • Top 10 reading guide
    • US-EN Location: United States-English  
    • Contact us
      • Dashboard
      • Saved items
      • Content feed
      • Subscriptions
      • Profile/Interests
      • Account settings
    05 October 2018

    CDOs, health data, and the Open Science movement

    05 October 2018
    • Dr. Juergen Klenk United States
    • Save for later
    • Download
    • Share
      • Share on Facebook
      • Share on Twitter
      • Share on Linkedin
      • Share by email
    • Open Science: In need of champions
    • Now is the time for Open Science
    • Government CDOs can help accelerate Open Science
    • Overcoming the barriers: Technology, policy, and culture
    • Looking ahead

    ​Government CDOs may be among the best placed to encourage health care stakeholders to practice Open Science—the idea that knowledge must flow freely across the scientific community to accelerate breakthroughs that benefit society.

    Open Science: In need of champions

    The health care sector is teeming with data. Electronic health records, technologies such as smart watches and mobile apps, and major advances in scientific research—especially in the areas of imaging and genomic sequencing—have given us volumes of medical and biological data over the last decade. One might assume that such a data-rich landscape inherently accelerates scientific discoveries. However, reams of data alone cannot generate new insights, especially when they exist in silos, as is often the case today.

    Open Science—the notion that scientific research, including data and research methodologies, should be open and accessible—can offer a solution. Without powerful champions, however, such openness may remain the exception rather than the rule. Practicing Open Science inherently requires cross-sector collaboration as well as buy-in from the public. This is where government chief data officers (CDOs) could play a key role.

    Learn More

    Read the full CDO Playbook

    Create a custom PDF

    Learn more about the Beeck Center

    Subscribe to receive public sector content from Deloitte Insights

    Now is the time for Open Science

    The early stages of the Open Science movement can be traced back to the 17th century, when the idea arose that knowledge must flow freely across the scientific community to enable and accelerate scientific breakthroughs that can benefit all of society.1 Four centuries later, Open Science remains an idea that has yet to be fully realized. However, collaborative tools and digital technologies are making the endeavor more achievable than ever before. Rather than simply sharing knowledge in scientific journals, we now have the ability to share electronic health records, patient-generated data, insurance claims data—even genomic data—in standardized, interoperable formats through web-based tools and the cloud. Moreover, with advanced analytics and cognitive technologies, we can process large volumes of data to identify complex patterns that can lead to new discoveries in ways that were almost unimaginable until recently. Using these data and tools is essential to achieving Open Science’s so-called FAIR principles—that data should be findable, accessible, interoperable, and reusable2 (see the sidebar, “What is FAIR?”).

    What is FAIR?3

    The FAIR principles are a set of guiding principles for scientific data management and stewardship to support innovation and discovery. Distinct from peer initiatives that focus on the human scholar, the FAIR principles put specific emphasis on enhancing the ability of machines to automatically find and use data—in other words, making data “machine-actionable”—in addition to supporting its reuse by individuals. Widely recognized and supported in the scientific community, the principles posit that data should be:

    • Findable. Data must have unique identifiers that effectively label it within searchable resources.
    • Accessible. Data must be easily retrievable via open systems that have effective and secure authentication and authorization procedures.
    • Interoperable. Data should “use and speak the same language” by using standardized vocabularies.
    • Reusable. Data must be adequately described to a new user, include clear information about data usage licenses, and have a traceable “owner’s manual” or provenance.

    Consider cancer research. Dr. Jay Bradner, a doctor at a small Harvard-sponsored cancer lab, created a molecule called JQ1—a prototype for a drug to target a rare type of cancer. Rather than keeping the prototype a secret until it was turned into an active pharmaceutical substance and patented, the lab made the drug’s chemical identity available on its website for “open source drug discovery.” The concept of open source drug discovery borrows two principles from open source computing—collaboration and open access—and applied them to pharmaceutical innovation. Scientists from around the world were able to learn about the drug’s chemical identity so that they could experiment with it on various cancer cells. These scientists, in turn, have created new molecules to treat cancer that are being tested in clinical trials.4 Collaborations like these allow hundreds of minds to study the individual pieces of a complex problem, multiplying the usual pace of discovery.

    Government CDOs can help accelerate Open Science

    Federal and state governments—and their CDOs—have two unique levers that they can apply to encourage greater openness and collaboration: They hold enormous quantities of health data, and they have the ability to influence policy and practice.

    US government health data derives from public programs like Medicare and Medicaid, which collectively cover one in three people in the United States;5 government-sponsored disease registries; the Million Veteran Program (MVP), one of the world’s largest medical databases, which has collected blood samples and health information from a million veteran volunteers; and the National Institutes of Health’s (NIH’s) recent All of Us initiative, a historic effort to gather data from 1 million or more US residents to accelerate research and improve health.6 In addition, federal agencies such as the Department of Health and Human Services (HHS), as well as a handful of states, cities, and counties around the country, have begun hiring CDOs to help determine how data is collected, organized, accessed, and analyzed. According to Project Open Data, an online public repository created by President Barack Obama’s Open Data Policy and Executive Order,7 the CDO’s role is “part data strategist and adviser, part steward for improving data quality, part evangelist for data sharing, part technologist, and part developer of new data products.”8

    CDOs looking to advance Open Science should consider ways to meaningfully share more government health data and to encourage nongovernment stakeholders, including academic researchers, health providers, and ordinary citizens, to participate in Open Science data platforms and share their own data. To do so, they will need to address the various technological, policy, and cultural challenges.

    Overcoming the barriers: Technology, policy, and culture

    Technology: Moving government health data to the cloud

    Open Science requires a technological infrastructure that allows data to be securely shared, stored, and analyzed. In an effort to develop this infrastructure, the NIH has begun piloting a “Data Commons,” a virtual space where scientists can store, access, and share biomedical data and tools. Here, researchers can utilize “digital objects of biomedical research” to solve difficult problems together and apply cognitive computing capabilities in a single cloud-based environment.9 This platform embraces the FAIR principles, including the need to safeguard the data it contains with secure authentication and authorization procedures. The pilot is due to be completed in 2020,10 after which lessons learned are expected to be incorporated into a number of permanent, interoperable, sustainably operated Data Commons spaces.

    A Data Commons, however, is only as good as the quality and quantity of the health data it contains. Government health agency CDOs can play an important role in increasing participation in Data Commons by moving their agency’s data from on-premise storage units to large-scale cloud platforms that are interoperable with the NIH’s Data Commons, making it more accessible. Equally important is to improve the quality of the shared data, which means putting it in formats that are findable, interoperable, and reusable—that is to say, making it machine-actionable.

    Policy: Educating stakeholders and implementing data-sharing regulations

    The legal and regulatory landscape surrounding what data can be shared, with whom, and for what purpose can be a source of confusion and caution among health care providers and institutions that collect or generate health data. The real and/or perceived ethical, civil, privacy, or criminal risks associated with data-sharing have led many researchers and health care stakeholders to avoid doing so entirely unless they feel it is essential. This “better safe than sorry” approach can impede high-impact, timely, and resource-efficient discovery science. Furthermore, in academia, a researcher’s career advancement can depend on his or her ability to attract grant funding, which in turn depends on his or her ability to generate peer-reviewed publications. In this competitive environment, researchers have little incentive to collaborate with and share their valuable data with their peers. On top of these barriers, the effort and cost associated with making data FAIR are significant.

    Government CDOs have an opportunity to overcome such barriers to data-sharing through a combination of education, support structures, and appropriate policies and governance principles. CDOs could conduct educational outreach to academics, health care providers, and other stakeholders to clarify data privacy laws such as the Health Insurance Portability and Accountability Act (HIPAA) and the Health Information Technology for Economic and Clinical Health (HITECH) Act. The goal would be to help these stakeholders understand that, rather than prohibiting data-sharing, these laws merely define parameters around when and how to share data. Through written materials, videos, and live workshops, CDOs can clarify regulatory requirements to encourage data-sharing among health care stakeholders and individuals who are being asked to share their personal health information.

    In addition to educating stakeholders, CDOs can prompt agencies to take advantage of certain policies that allow government agencies to require data-sharing. The 21st-Century Cures Act, for instance, gives the director of the NIH the authority to require that data from NIH-supported research be openly shared to accelerate the pace of biomedical research and discovery.11 Such policies must be complemented with appropriate benefits for researchers who share their data—for instance, giving such researchers appropriate consideration for additional grants and/or naming them as co-authors on publications that use their data.

    Culture: Engage the broader community

    Open Science requires cross-sector participation and engagement from government entities, health care stakeholders, researchers, and the public. As part of their efforts to evangelize data-sharing, CDOs should consider engaging the broader community by stoking genuine interest and appreciation of the crucial role data-sharing plays in science and innovation and the benefits every player can gain from it.

    One way of engaging health care stakeholders and scientists is by giving them access to appropriate government data and tools so that they can begin using shared data and seeing its value for themselves. Another way is to seek innovative solutions to health and scientific challenges using community engagement models such as code-a-thons, contests, and crowdsourcing.12 CDOs can also encourage the general public to ensure that their data contributes to Open Science by educating them on how they can—directly or through patient advocacy organizations—encourage researchers and clinicians to share the data they collect. Lastly, with private individuals increasingly generating large volumes of valuable health data through wearables and mobile devices, CDOs can help such individuals understand how they could best share this data with researchers.

    Looking ahead

    The proliferation of digital health data, coupled with advanced computational capacity and interoperable platforms such as Data Commons, gives society the basic tools to practice Open Science in health care research. However, making Open Science a reality will require all health care stakeholders, including ordinary citizens, to participate.13

    Government CDOs can accelerate the spread of Open Science in several ways. They can establish policies and governance principles that encourage data-sharing. They can conduct education, outreach, and community engagement efforts to help stakeholders understand why and how to share data and to encourage them to do so. And they can serve as role models by making their own agencies’ data available for appropriate public use.

    Like all important movements, Open Science will likely face ongoing challenges. Those at the helm will need to balance the opportunities it provides with the inherent risks, including those related to data privacy and security. Of all the stakeholders in scientific discovery, government CDOs may be among the best placed to help society sort through these opportunities and risks. As public servants, they have every incentive to embrace a leadership role in promoting Open Science for the common good.

    Authors

    Dr. Juergen Klenk is a principal with Deloitte Consulting LLP’s Monitor Strategy practice, focusing on advancing precision medicine and data science in health care and biomedical research. He is based in Arlington, VA.
    Melissa Majerol leads the Deloitte Center for Government Insights’ health care research agenda. She is based in Washington, DC.

    Acknowledgments

    Cover image by: Lucie Rice

    Endnotes
      1. Foster, “Open Science definition,” accessed August 1, 2018; Sarita Albagli, Maria Lucia Maciel, and Alexandre Hannud Abdo, Open Science, open issues, Brazilian Institute for Information in Science and Technology (IBICT) and Federal University of the State of Rio de Janeiro (UNIRIO), accessed August 1, 2018. View in article

      2. Mark D. Wilkinson et al., “The FAIR guiding principles for scientific data management and stewardship,” Scientific Data 15, no. 3 (2016): DOI: 10.1038/sdata.2016.18. View in article

      3. Mark D. Wilkinson et al., “The FAIR guiding principles for scientific data management and stewardship,” Scientific Data 15, no. 3 (2016). View in article

      4. National Public Radio (NPR), Ted Radio Hour, “How will open-source research help cure cancer?,” transcript, July 31, 2015. View in article

      5. Center for Medicare and Medicaid Services (CMS), “Medicare and Medicaid: Keeping us healthy for 50 Years,” accessed August 22, 2018. View in article

      6. US Department of Veterans Affairs, “Million Veteran Program,” accessed August 1, 2018; National Institutes of Health, “The All of Us research program,” accessed August 1, 2018. View in article

      7. Todd Park and Steven Vanroekel, “Introducing: Project Open Data,” The White House, President Barack Obama, May 16, 2013. View in article

      8. Project Open Data, “CDO position description,” accessed August 22, 2018. View in article

      9. National Institutes of Health, Office of Strategic Coordination—The Common Fund, “New models of data stewardship—Data Commons pilot,” July 24, 2018. View in article

      10. Ibid. View in article

      11. Kathy L. Hudson and Francis S. Collins, “The 21st century Cures Act—A view from NIH,” New England Journal of Medicine, 376 (2017): pp. 111–3, DOI: 10.1056/NEJMp1615745. View in article

      12. National Institutes of Health (NIH), NIH strategic plan for data science, accessed August 22, 2018. View in article

      13. J. Klenk et al., “Open science and the future of data analytics,” in M. Edmunds, C. Hass, and E. Holve (Eds.), Consumer Informatics and Digital Health (Springer, 2018). View in article

    Show moreShow less

    Topics in this article

    C-suite , Government , Public Sector , Health Information Technology , Life Sciences

    Deloitte Center for Government Insights

    Learn more

    Download Subscribe

    The chief data officer in government: A playbook for CDOs

    img Trending

    Data tokenization for government

    Article 3 years ago
    img Trending

    Data as an asset

    Article 3 years ago
    img Trending

    Pump your own data

    Article 3 years ago
    img Trending

    Managing data ethics

    Article 3 years ago

    Read more from the playbook

    • How CDOs can promote machine learning in government Article4 years ago
    • Implementing the DATA Act Article4 years ago
    • How CDOs can manage algorithmic risks Article4 years ago
    • How CDOs can overcome obstacles to open data-sharing Article4 years ago
    • Connecting data to residents through data storytelling Article4 years ago
    • Turning public data to the public good Article4 years ago
    Dr. Juergen Klenk

    Dr. Juergen Klenk

    Principal | Deloitte Consulting LLP

    Juergen Klenk, PhD, is a principal with Deloitte Consulting LLP’s Monitor Strategy practice. He focuses on advancing precision medicine and data science in health care and biomedical research through the unique lens of his combined formal scientific training and entrepreneurial experience. Klenk is based in Arlington, VA.

    • jklenk@deloitte.com
    • +1 571 858 1141

    Share article highlights

    See something interesting? Simply select text and choose how to share it:

    Email a customized link that shows your highlighted text.
    Copy a customized link that shows your highlighted text.
    Copy your highlighted text.

    CDOs, health data, and the Open Science movement has been saved

    CDOs, health data, and the Open Science movement has been removed

    An Article Titled CDOs, health data, and the Open Science movement already exists in Saved items

    Invalid special characters found 
    Forgot password

    To stay logged in, change your functional cookie settings.

    OR

    Social login not available on Microsoft Edge browser at this time.

    Connect Accounts

    Connect your social accounts

    This is the first time you have logged in with a social network.

    You have previously logged in with a different account. To link your accounts, please re-authenticate.

    Log in with an existing social network:

    To connect with your existing account, please enter your password:

    OR

    Log in with an existing site account:

    To connect with your existing account, please enter your password:

    Forgot password

    Subscribe

    to receive more business insights, analysis, and perspectives from Deloitte Insights
    ✓ Link copied to clipboard
    • Contact us
    • Search jobs
    • Submit RFP
    • Subscribe to Deloitte Insights
    Follow Deloitte Insights:
    Global office directory US office locations
    US-EN Location: United States-English  
    About Deloitte
    • About Deloitte
    • Client stories
    • My Deloitte
    • Deloitte Insights
    • Email subscriptions
    • Press releases
    • Submit RFP
    • US office locations
    • Alumni
    • Global office directory
    • Newsroom
    • Dbriefs webcasts
    • Contact us
    Services
    • Tax
    • Consulting
    • Audit & Assurance
    • Deloitte Private
    • M&A and Restructuring
    • Risk & Financial Advisory
    • AI & Analytics
    • Cloud
    • Diversity, Equity & Inclusion
    Industries
    • Consumer
    • Energy, Resources & Industrials
    • Financial Services
    • Government & Public Services
    • Life Sciences & Health Care
    • Technology, Media & Telecommunications
    Careers
    • Careers
    • Students
    • Experienced Professionals
    • Job Search
    • Life at Deloitte
    • Alumni Relations
    • About Deloitte
    • Terms of Use
    • Privacy
    • Privacy Shield
    • Cookies
    • Cookie Settings
    • Legal Information for Job Seekers
    • Labor Condition Applications
    • Do Not Sell My Personal Information

    © 2023. See Terms of Use for more information.

    Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee ("DTTL"), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as "Deloitte Global") does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the "Deloitte" name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see www.deloitte.com/about to learn more about our global network of member firms.

    Learn more about Deloitte's work for the US Olympic Committee